http://www.judges.uk.com/


Judges Scientific plc (formerly Judges Capital plc)

Judges Scientific is an AIM-listed company specialising in the design and production of scientific instruments. Rapid expansion is being pursued, both through organic growth within its subsidiary companies and through the acquisition of top-quality businesses with established reputations in world-wide markets.
Judges Scientific is a mini-conglomerate focused on scientific instruments. It owns seven specialised businesses, such as Fire Testing Technology, which measures the way materials react to fire and Global Digital Systems, which tests soil and rock ahead of large civil engineering projects.
These businesses are diverse, but they are all based in Britain and they all sell their products and services worldwide.


http://www.aitcheeengineering.co.uk/
http://www.fire-testing.com/

Final results



Highlights:


· Record revenues of £40.6 million (2013: £36.0 million) but a 3.0% decrease on a like-for-like basis

· Pre-tax profit before exceptional items and non-controlling interests down 11.8% to £6.5 million (2013: £7.3 million)

· Basic earnings per share, excluding exceptional items, down 17.7% to 82.7p (2013: 100.5p); corresponding figures including exceptional items: 35.7p (2013: 23.4p)

· Fully diluted earnings per share, excluding exceptional items, down 16.5% to 80.5p (2013: 96.4p)

· Proposed final dividend of 14.7p (2013: 13.4p), making a total distribution for the year of 22.0p (2013: 20.0p), a 10.0% increase

· Cash generated from operations of £7.5 million (2013: £5.0 million)

· Cash in hand of £11.1 million as at 31 December 2014; adjusted net debt of £1.3 million (2013: £5.2 million)

· New £10 million acquisition facility arranged in December

· Acquisition of Armfield Limited post year end

Ex-Dividend
11 Jun 15 Judges Scientific PLC [JDG] (14.7 p)

Judges in £1.4m earn-out payment for Armfield
StockMarketWire.com
Judges Scientific has issued 36,738 new ordinary shares as part of a £1.4m earn-out payment for Armfield which was acquired in January.

The consideration payable on completion amounted to £8.28m in cash. In addition, there was provision for the payment of an earn-out capped at £1.51m, based upon achievement of a profit threshold of £1.96m in respect of the year to 31 December 2014.

Half of the earn-out was payable in cash and half through the issue of new ordinary shares in Judges at a price of £20.55 per ordinary share, based on the prevailing price of Judges' ordinary shares on the day the headline terms of the acquisition were agreed.

Accounts for the earn-out period have now been agreed and the directors of Judges are pleased to announce that the profit threshold was attained.

Accordingly, the additional cash consideration relating to the deferred consideration has been paid and the company has today issued 36,738 new Ordinary Shares to the vendors of Armfield.

Application has been made for these new Ordinary Shares to be admitted to AIM and dealings are expected to commence on 29 May 2015. The closing mid-market price of £16.825 per ordinary share on 21 May values the earn-out shares at £618,117.

This gives a total earn-out value of £1,373,117 and takes the total consideration paid for Armfield to £9,653,117.

Preliminary Results
RNS
RNS Number : 2060I
Judges Scientific PLC
20 March 2018

20 March 2018
Judges Scientific plc
("Judges Scientific", "Judges", the "Company" or the "Group")
PRELIMINARY STATEMENT OF RESULTS

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, is pleased to announce its Preliminary Results for the year ended 31 December 2017.

Financial Highlights:

· Revenues up 24.6% to a record £71.4 million (2016: £57.3 million), including 17.7% Organic* growth;
· Adjusted** operating profit up 52% to £10.9 million (2016: £7.1 million);
o Statutory operating profit of £5.7 million (2016: £1.0 million);
· Adjusted** basic earnings per share up 56% to 131.9p (2016: 84.8p);
o Statutory basic earnings per share of 65.6p (2016: 1.0p);
· Final dividend of 22p, totalling 32p for the year, an increase of 16%; covered 4 times by adjusted earnings;
· Organic* order intake up 16% compared with 2016;
· Organic* order book at 16.6 weeks (1 January 2017: 14.8 weeks);
· Cash generated from operations of £10.9 million (2016: £6.2 million);
· Adjusted** net debt of £8.0 million as at 31 December 2017 (31 December 2016: £9.9 million);
o Statutory net debt of £7.6 million at 31 December 2017 (31 December 2016: £8.6 million);
· Cash balances of £10.7 million as at 31 December 2017 (31 December 2016: £7.9 million).

Strategic Highlights
· Acquisition of Oxford Cryosystems by Bordeaux on 18 July 2017 for £5.1m cash (including earn-out);
· Increase in Judges' shareholding in Bordeaux to 75.5%.

* Organic describes the performance of the Group including businesses acquired prior to 1 January 2016.
** Adjusted earnings figures exclude adjusting items relating to amortisation of intangible assets, acquisition-related costs, share based payments and hedging of risks materialising after the end of the year. Adjusted net debt includes acquisition-related liabilities and excludes subordinated debt owed by subsidiaries to minority shareholders.

Alex Hambro, Chairman of Judges Scientific, commented:

"2017 was a record year for order intake, sales, adjusted profits and earnings per share; this was driven by good demand for our products and very favourable foreign exchange rates."

Trading Update
RNS
RNS Number : 9628H
Judges Scientific PLC
21 November 2018


21 November 2018

Judges Scientific plc (the "Group" or "Judges")
Trading Update
EPS expected to be ahead of current market expectations
The Board of Judges Scientific, a group involved in the buy and build of scientific instrument businesses, updates shareholders and the market on the Group's trading performance in the financial year ending 31 December 2018.
Trading has remained strong since the publication of the interim results and the healthy order intake communicated at the time of the results has continued since the beginning of the second half. As a result, the Board expects Earnings per Share for the full year ending 31 December 2018 to exceed current market expectations as increased in September.